AI assistant
Sending…
Bioventus Inc. — Director's Dealing 2021
Sep 10, 2021
32934_dirs_2021-09-10_86b72d88-6c9a-432e-90c0-ec1bcadf6c28.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-09-09
Reporting Person: Reali Kenneth Michael (Director, CHIEF EXECUTIVE OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-09 | Class A Common Stock | P | 1800 | $14.81 | Acquired | 11175 | Direct |
More from Bioventus Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17